Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03648164 · ClinicalTrials.gov registry record
CREATION Health Assessment Tool for College Students
A clinical trial, sponsored by AdventHealth.
- Completed
- Registry status
- 474
- Enrollment target
NCT03648164: Completed study, sponsored by AdventHealth.
NCT03648164 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 474 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03648164 has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 474 participants
- Enrollment target
Study Summary
CREATION Health encompasses eight whole-person care principles: Choice, Rest, Environment, Activity, Trust, Interpersonal-Relationships, Outlook, and Nutrition. An existing initial tool consisting of 74 items related to the eight CREATION Health principles and college students' wellbeing were generated by subject/methodology experts. To develop the CREATION Health Assessment Tool for College Students (CHAT-CS), this initial tool needs to be finalized through item reductions and validations in the population of college students.
Primary Outcome
Cronbach's (alpha) is a coefficient of reliability. The theoretical l value of the Cronbach's alpha varies from 0 to 1. A higher score indicates higher reliability.
Interventions
- OTHER CHAT-CS Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 474 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-07-09 |
What the finished NCT03648164 record still lists
NCT03648164 is an observational study that tracks outcomes without assigning an intervention. The registered 474 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CHAT-CS Survey is the first listed.
NCT03648164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03648164 about?
NCT03648164 is a clinical study titled "CREATION Health Assessment Tool for College Students". CREATION Health encompasses eight whole-person care principles: Choice, Rest, Environment, Activity, Trust, Interpersonal-Relationships, Outlook, and Nutrition. An existing initial tool consisting of 74 items related to the eight CREATION Health principles and college students' wellbeing were genera...
What is the current status of trial NCT03648164?
This trial is currently completed. The enrollment target is 474 participants. The study started on 2018-10-01. Estimated completion is 2019-07-09.
What interventions are being tested in trial NCT03648164?
The interventions under investigation include: CHAT-CS Survey (OTHER).
Who is sponsoring clinical trial NCT03648164?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05624996 · 474 participants · Phase 3
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- NCT06051695 · 474 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NCT06632977 · 474 participants · Phase 2
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- NCT01788839 · 475 participants
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI